Discussing the treatment landscape for diffuse large B-Cell Lymphoma and the uptake of ADC Therapeutics' Zynlonta

Executed on:Jan 29, 2024 3:00 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: University of Miami

Professor of Medicine and the Director of Lymphoma Program and Chief of Lymphoma Section at Sylvester Comprehensive Cancer Center at University of Miami.
Research focuses on the pathogenesis of lymphoma, identification of molecular prognostic markers and elucidation of their role in determination of response to therapy, development of new lymphoma therapies.
PI or Co-PI on numerous trials; his studies focus on diffuse large cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, primary CNS lymphoma, lymphomas of the eye and other lymphoma subtypes.

Interview Goal

discuss the commercial use of Zynlonta, and what the typical treatment paradigm currently looks like

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.